{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:06:18Z","timestamp":1761764778544},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2006,9,18]],"date-time":"2006-09-18T00:00:00Z","timestamp":1158537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,18]],"date-time":"2006-09-18T00:00:00Z","timestamp":1158537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2007,3,22]]},"DOI":"10.1038\/sj.onc.1209979","type":"journal-article","created":{"date-parts":[[2006,9,18]],"date-time":"2006-09-18T16:35:40Z","timestamp":1158597340000},"page":"1910-1919","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes"],"prefix":"10.1038","volume":"26","author":[{"given":"F","family":"Habens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A S","family":"Lapham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C L","family":"Dallman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B M","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Michels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E G","family":"Marcusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P W M","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Packham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,18]]},"reference":[{"key":"BF1209979_CR1","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.4049\/jimmunol.165.7.3860","volume":"165","author":"S Andjelic","year":"2000","unstructured":"Andjelic S, Hsia C, Suzuki H, Kadowaki T, Koyasu S, Liou HC . (2000). Phosphatidylinositol 3-kinase and NF-kappa B\/Rel are at the divergence of CD40-mediated proliferation and survival pathways. J Immunol 165: 3860\u20133867.","journal-title":"J Immunol"},{"key":"BF1209979_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/bbrc.1998.8907","volume":"248","author":"J Ban","year":"1998","unstructured":"Ban J, Eckhart L, Weninger W, Mildner M, Tschachler E . (1998). Identification of a human cDNA encoding a novel Bcl-x isoform. Biochem Biophys Res Commun 248: 147\u2013152.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF1209979_CR3","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0002-9440(10)64080-1","volume":"158","author":"A Biroccio","year":"2001","unstructured":"Biroccio A, Benassi B, D'Agnano C, Buglioni S, Mottolese M, Ricciotti A et al. (2001). c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings. Am J Pathol 158: 1289\u20131299.","journal-title":"Am J Pathol"},{"key":"BF1209979_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0092-8674(93)90508-N","volume":"74","author":"LH Boise","year":"1993","unstructured":"Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA et al. (1993). Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597\u2013608.","journal-title":"Cell"},{"key":"BF1209979_CR5","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/sj.onc.1201704","volume":"16","author":"M Brimmell","year":"1998","unstructured":"Brimmell M, Mendiola R, Mangion J, Packham G . (1998). BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16: 1803\u20131812.","journal-title":"Oncogene"},{"key":"BF1209979_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.immunol.16.1.395","volume":"16","author":"DT Chao","year":"1998","unstructured":"Chao DT, Korsmeyer SJ . (1998). BCL-2 family: regulators of cell death. Annu Rev Immunol 16: 395\u2013419.","journal-title":"Annu Rev Immunol"},{"key":"BF1209979_CR7","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1128\/MCB.20.8.2687-2695.2000","volume":"20","author":"C Chen","year":"2000","unstructured":"Chen C, Edelstein LC, Gelinas C . (2000). The Rel\/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20: 2687\u20132695.","journal-title":"Mol Cell Biol"},{"key":"BF1209979_CR8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/eji.1830250533","volume":"25","author":"MS Choi","year":"1995","unstructured":"Choi MS, Boise LH, Gottschalk AR, Quintans J, Thompson CB, Klaus GG . (1995). The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Eur J Immunol 25: 1352\u20131357.","journal-title":"Eur J Immunol"},{"key":"BF1209979_CR9","first-page":"1","volume":"115","author":"C Dallman","year":"2005","unstructured":"Dallman C, Packham G . (2005). Purification of primary malignant B-cells and immunoblot analysis of bcl-2 family proteins. Methods Mol Med 115: 1\u201313.","journal-title":"Methods Mol Med"},{"key":"BF1209979_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/BF03401913","volume":"4","author":"G Deng","year":"1998","unstructured":"Deng G, Lane C, Kornblau S, Goodacre A, Snell V, Andreeff M et al. (1998). Ratio of bcl-xshort to bcl-xlong is different in good- and poor-prognosis subsets of acute myeloid leukemia. Mol Med 4: 158\u2013164.","journal-title":"Mol Med"},{"key":"BF1209979_CR11","first-page":"2267","volume":"61","author":"F de Nigris","year":"2001","unstructured":"de Nigris F, Mega T, Berger N, Barone MV, Santoro M, Viglietto G et al. (2001). Induction of ETS-1 and ETS-2 transcription factors is required for thyroid cell transformation. Cancer Res 61: 2267\u20132275.","journal-title":"Cancer Res"},{"key":"BF1209979_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/blood.V100.1.194","volume":"100","author":"S Derenne","year":"2002","unstructured":"Derenne S, Monia B, Dean NM, Taylor JK, Rapp MJ, Harousseau JL et al. (2002). Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. Blood 100: 194\u2013199.","journal-title":"Blood"},{"key":"BF1209979_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0092-8674(02)00972-8","volume":"111","author":"BE Deverman","year":"2002","unstructured":"Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosova I et al. (2002). Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 111: 51\u201362.","journal-title":"Cell"},{"key":"BF1209979_CR14","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1038\/sj.onc.1202796","volume":"18","author":"S Dumon","year":"1999","unstructured":"Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C et al. (1999). IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene 18: 4191\u20134199.","journal-title":"Oncogene"},{"key":"BF1209979_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1046\/j.1365-2141.2001.02603.x","volume":"112","author":"DA Fennell","year":"2001","unstructured":"Fennell DA, Corbo MV, Dean NM, Monia BP, Cotter FE . (2001). In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID\/NOD-Hu model. Br J Haematol 112: 706\u2013713.","journal-title":"Br J Haematol"},{"key":"BF1209979_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/00000658-199812000-00009","volume":"228","author":"H Friess","year":"1998","unstructured":"Friess H, Lu Z, Andren-Sandberg A, Berberat P, Zimmermann A, Adler G et al. (1998). Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer. Ann Surg 228: 780\u2013787.","journal-title":"Ann Surg"},{"key":"BF1209979_CR17","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1046\/j.1471-4159.2000.0751377.x","volume":"75","author":"JN Glasgow","year":"2000","unstructured":"Glasgow JN, Wood T, Perez-Polo JR . (2000). Identification and characterization of nuclear factor kappaB binding sites in the murine bcl-x promoter. J Neurochem 75: 1377\u20131389.","journal-title":"J Neurochem"},{"key":"BF1209979_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00001622-200011000-00006","volume":"12","author":"JM Grad","year":"2000","unstructured":"Grad JM, Zeng XR, Boise LH . (2000). Regulation of Bcl-xL: a little bit of this and a little bit of STAT. Curr Opin Oncol 12: 543\u2013549.","journal-title":"Curr Opin Oncol"},{"key":"BF1209979_CR19","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.4049\/jimmunol.158.10.4750","volume":"158","author":"DA Grillot","year":"1997","unstructured":"Grillot DA, Gonzalez-Garcia M, Ekhterae D, Duan L, Inohara N, Ohta S et al. (1997). Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol 158: 4750\u20134757.","journal-title":"J Immunol"},{"key":"BF1209979_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ijc.10248","volume":"99","author":"E Heere-Ress","year":"2002","unstructured":"Heere-Ress E, Thallinger C, Lucas T, Schlagbauer-Wadl H, Wacheck V, Monia BP et al. (2002). Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy. Int J Cancer 99: 29\u201334.","journal-title":"Int J Cancer"},{"key":"BF1209979_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/jcb.20012","volume":"91","author":"T Hsu","year":"2004","unstructured":"Hsu T, Trojanowska M, Watson DK . (2004). Ets proteins in biological control and cancer. J Cell Biochem 91: 896\u2013903.","journal-title":"J Cell Biochem"},{"key":"BF1209979_CR22","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1128\/JVI.75.5.2400-2410.2001","volume":"75","author":"GJ Inman","year":"2001","unstructured":"Inman GJ, Binne UK, Parker GA, Farrell PJ, Allday MJ . (2001). Activators of the Epstein\u2013Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death. J Virol 75: 2400\u20132410.","journal-title":"J Virol"},{"key":"BF1209979_CR23","doi-asserted-by":"publisher","first-page":"46378","DOI":"10.1074\/jbc.M305189200","volume":"278","author":"BJ Irvin","year":"2003","unstructured":"Irvin BJ, Wood LD, Wang L, Fenrick R, Sansam CG, Packham G et al. (2003). TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL. J Biol Chem 278: 46378\u201346386.","journal-title":"J Biol Chem"},{"key":"BF1209979_CR24","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.4049\/jimmunol.155.12.5527","volume":"155","author":"T Ishida","year":"1995","unstructured":"Ishida T, Kobayashi N, Tojo T, Ishida S, Yamamoto T, Inoue J . (1995). CD40 signaling-mediated induction of Bcl-XL, CdK4, and CdK6. Implication of their co-operation in selective B cell growth. J Immunol 155: 5527\u20135535.","journal-title":"J Immunol"},{"key":"BF1209979_CR25","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.1158\/0008-5472.CAN-03-3500","volume":"64","author":"AR Jazirehi","year":"2004","unstructured":"Jazirehi AR, Vega MI, Chatterjee D, Goodglick L, Bonavida B . (2004). Inhibition of the Raf-MEK1\/2-ERK1\/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Cancer Res 64: 7117\u20137126.","journal-title":"Cancer Res"},{"key":"BF1209979_CR26","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.1074\/jbc.M109824200","volume":"277","author":"K Kirito","year":"2002","unstructured":"Kirito K, Watanabe T, Sawada K, Endo H, Ozawa K, Komatsu N . (2002). Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways. J Biol Chem 277: 8329\u20138337.","journal-title":"J Biol Chem"},{"key":"BF1209979_CR27","first-page":"1449","volume":"149","author":"M Krajewska","year":"1996","unstructured":"Krajewska M, Fenoglio-Preiser CM, Krajewski S, Song K, Macdonald JS, Stemmerman G et al. (1996a). Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol 149: 1449\u20131457.","journal-title":"Am J Pathol"},{"key":"BF1209979_CR28","first-page":"2422","volume":"56","author":"M Krajewska","year":"1996","unstructured":"Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC . (1996b). Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 56: 2422\u20132427.","journal-title":"Cancer Res"},{"key":"BF1209979_CR29","doi-asserted-by":"publisher","first-page":"9136","DOI":"10.1073\/pnas.96.16.9136","volume":"96","author":"HH Lee","year":"1999","unstructured":"Lee HH, Dadgostar H, Cheng Q, Shu J, Cheng G . (1999). NF-kappa B-mediated up-regulation of Bcl-x and Bfl-1\/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci USA 96: 9136\u20139141.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1209979_CR30","doi-asserted-by":"publisher","first-page":"18411","DOI":"10.1074\/jbc.M201368200","volume":"277","author":"JH Lee","year":"2002","unstructured":"Lee JH, Koo TH, Hwang BY, Lee JJ . (2002). Kaurane diterpene, Kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. J Biol Chem 277: 18411\u201318420.","journal-title":"J Biol Chem"},{"key":"BF1209979_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/(SICI)1097-0320(20000215)42:1<61::AID-CYTO9>3.0.CO;2-5","volume":"42","author":"CM Lohmann","year":"2000","unstructured":"Lohmann CM, League AA, Clark WS, Lawson D, DeRose PB, Cohen C . (2000). Bcl-2: bax and bcl-2: Bcl-x ratios by image cytometric quantitation of immunohistochemical expression in ovarian carcinoma: correlation with prognosis. Cytometry 42: 61\u201366.","journal-title":"Cytometry"},{"key":"BF1209979_CR32","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1038\/sj.onc.1203949","volume":"19","author":"L MacCarthy-Morrogh","year":"2000","unstructured":"MacCarthy-Morrogh L, Wood L, Brimmell M, Johnson PW, Packham G . (2000). Identification of a novel human BCL-X promotor and exon. Oncogene 19: 5534\u20135538.","journal-title":"Oncogene"},{"key":"BF1209979_CR33","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1038\/sj.onc.1207648","volume":"23","author":"J Michels","year":"2004","unstructured":"Michels J, O'Neill JW, Dallman CL, Mouzakiti A, Habens F, Brimmell M et al. (2004). Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene 23: 4818\u20134827.","journal-title":"Oncogene"},{"key":"BF1209979_CR34","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1126\/science.7878471","volume":"267","author":"N Motoyama","year":"1995","unstructured":"Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Nakayama K et al. (1995). Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267: 1506\u20131510.","journal-title":"Science"},{"key":"BF1209979_CR35","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1101\/gad.10.17.2105","volume":"10","author":"P Naik","year":"1996","unstructured":"Naik P, Karrim J, Hanahan D . (1996). The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributed to tumor progression from angiogenic progenitors. Genes Dev 10: 2105\u20132116.","journal-title":"Genes Dev"},{"key":"BF1209979_CR36","first-page":"230","volume":"3","author":"OI Olopade","year":"1997","unstructured":"Olopade OI, Adeyanju MO, Safa AR, Hagos F, Mick R, Thompson CB et al. (1997). Overexpressing of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am 3: 230\u2013237.","journal-title":"Cancer J Sci Am"},{"key":"BF1209979_CR37","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1101\/gad.12.16.2475","volume":"12","author":"G Packham","year":"1998","unstructured":"Packham G, White EL, Eischen CM, Yang H, Parganas E, Ihle JN et al. (1998). Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev 12: 2475\u20132487.","journal-title":"Genes Dev"},{"key":"BF1209979_CR38","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/sj.leu.2400705","volume":"11","author":"M Pallis","year":"1997","unstructured":"Pallis M, Zhu YM, Russell NH . (1997). Bcl-x(L) is heterogenously expressed by acute myeloblastic leukemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression. Leukemia 11: 945\u2013949.","journal-title":"Leukemia"},{"key":"BF1209979_CR39","doi-asserted-by":"publisher","first-page":"21062","DOI":"10.1074\/jbc.M008665200","volume":"276","author":"A Pecci","year":"2001","unstructured":"Pecci A, Viegas LR, Baranao JL, Beato M . (2001). Promotor choice influences alternative splicing and determines the balanced isoforms expressed from the mouse bcl-x gene. J Biol Chem 276: 21062\u201321069.","journal-title":"J Biol Chem"},{"key":"BF1209979_CR40","first-page":"2111","volume":"58","author":"JC Pena","year":"1998","unstructured":"Pena JC, Rudin CM, Thompson CB . (1998). A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res 58: 2111\u20132116.","journal-title":"Cancer Res"},{"key":"BF1209979_CR41","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.ejca.2005.08.013","volume":"41","author":"A Seth","year":"2005","unstructured":"Seth A, Watson DK . (2005). ETS transcription factors and their emerging role in human cancer. Eur J Cancer 41: 2462\u20132478.","journal-title":"Eur J Cancer"},{"key":"BF1209979_CR42","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1128\/MCB.19.4.2624","volume":"19","author":"L Sevilla","year":"1999","unstructured":"Sevilla L, Aperlo C, Dulic V, Chambard JC, Boutonnet C, Pasquier O et al. (1999). The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism. Mol Cell Biol 19: 2624\u20132634.","journal-title":"Mol Cell Biol"},{"key":"BF1209979_CR43","first-page":"595","volume":"16","author":"L Sevilla","year":"2001","unstructured":"Sevilla L, Zaldumbide A, Pognonec P, Boulukos KE . (2001). Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel\/NfkappaB, STAT and AP1 transcription factor families. Histol Histopathol 16: 595\u2013601.","journal-title":"Histol Histopathol"},{"key":"BF1209979_CR44","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1128\/JVI.73.6.4678-4688.1999","volume":"73","author":"LC Spender","year":"1999","unstructured":"Spender LC, Cannell EJ, Hollyoake M, Wensing B, Gawn JM, Brimmell M et al. (1999). Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein\u2013Barr virus. J Virol 73: 4678\u20134688.","journal-title":"J Virol"},{"key":"BF1209979_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF00571929","volume":"5","author":"K Takada","year":"1991","unstructured":"Takada K, Horinouchi K, Ono Y, Aya T, Osato T, Takahashi M et al. (1991). An Epstein\u2013Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5: 147\u2013156.","journal-title":"Virus Genes"},{"key":"BF1209979_CR46","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1128\/MCB.19.6.4452","volume":"19","author":"A Tamir","year":"1999","unstructured":"Tamir A, Howard J, Higgins RR, Li YJ, Berger L, Zacksenhaus E et al. (1999). Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol 19: 4452\u20134464.","journal-title":"Mol Cell Biol"},{"key":"BF1209979_CR47","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1038\/sj.onc.1202836","volume":"18","author":"JK Taylor","year":"1999","unstructured":"Taylor JK, Zhang QQ, Monia BP, Marcusson EG, Dean NM . (1999). Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli. Oncogene 18: 4495\u20134504.","journal-title":"Oncogene"},{"key":"BF1209979_CR48","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood-2002-04-1217","volume":"101","author":"C Tian","year":"2003","unstructured":"Tian C, Gregoli P, Bondurant M . (2003). The function of the bcl-x promoter in erythroid progenitor cells. Blood 101: 2235\u20132242.","journal-title":"Blood"},{"key":"BF1209979_CR49","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood.V88.4.1359.bloodjournal8841359","volume":"88","author":"JM Tuscano","year":"1996","unstructured":"Tuscano JM, Druey KM, Riva A, Pena J, Thompson CB, Kehrl JH . (1996). Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood 88: 1359\u20131364.","journal-title":"Blood"},{"key":"BF1209979_CR50","first-page":"256","volume":"58","author":"Y Tu","year":"1998","unstructured":"Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J et al. (1998). BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res 58: 256\u2013262.","journal-title":"Cancer Res"},{"key":"BF1209979_CR51","doi-asserted-by":"publisher","first-page":"8114","DOI":"10.1038\/sj.onc.1208954","volume":"24","author":"MI Vega","year":"2005","unstructured":"Vega MI, Huerta-Yepez S, Jazirehi AR, Garban H, Bonavida B . (2005). Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis. Oncogene 24: 8114\u20138127.","journal-title":"Oncogene"},{"key":"BF1209979_CR52","doi-asserted-by":"publisher","first-page":"9831","DOI":"10.1074\/jbc.M312402200","volume":"279","author":"LR Viegas","year":"2004","unstructured":"Viegas LR, Vicent GP, Baranao JL, Beato M, Pecci A . (2004). Steroid hormones induce bcl-X gene expression through direct activation of distal promoter. J Biol Chem 279: 9831\u20139839.","journal-title":"J Biol Chem"},{"key":"BF1209979_CR53","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.4049\/jimmunol.155.8.3722","volume":"155","author":"Z Wang","year":"1995","unstructured":"Wang Z, Karras JG, Howard RG, Rothstein TL . (1995). Induction of bcl-x by CD40 engagement rescues Sig-induced apoptosis in murine B cells. J Immunol 155: 3722\u20133725.","journal-title":"J Immunol"},{"key":"BF1209979_CR54","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4049\/jimmunol.174.1.180","volume":"174","author":"LX Wu","year":"2005","unstructured":"Wu LX, La Rose J, Chen L, Neale C, Mak T, Okkenhaug K et al. (2005). CD28 regulates the translation of Bcl-xL via the phosphatidylinositol 3-kinase\/mammalian target of rapamycin pathway. J Immunol 174: 180\u2013194.","journal-title":"J Immunol"},{"key":"BF1209979_CR55","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1046\/j.1365-2141.1996.423958.x","volume":"92","author":"L Xerri","year":"1996","unstructured":"Xerri L, Parc P, Brousset P, Schlaifer D, Hassoun J, Reed JC et al. (1996). Predominant expression of the long isoform of Bcl-x (Bcl-xL) in human lymphomas. Br J Haematol 92: 900\u2013906.","journal-title":"Br J Haematol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1209979.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1209979","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1209979.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T22:00:17Z","timestamp":1683583217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1209979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,18]]},"references-count":55,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2007,3,22]]}},"alternative-id":["BF1209979"],"URL":"https:\/\/doi.org\/10.1038\/sj.onc.1209979","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,18]]},"assertion":[{"value":"9 May 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}